{"F": {"ts_code": "US.LAB", "name": "Standard BioTools", "mkt": "US", "ccy": "美元", "sw1": "医疗设备", "sw2": "医疗设备", "sw3": "", "ind": "医疗设备", "fin_source": "futu", "market": "NASDAQ", "list_date": null, "is_fin": false, "roles": {"fin": false, "commodity": false, "precious": false, "regulated": false, "hard": false, "growth": true}, "province": null, "main_business": "", "introduction": "", "close": 0.6855, "pe_ttm": 3.115, "pb": 0.498, "dv_ttm": 0.0, "total_mv": 26911.2772884, "trade_date": "20260904", "years": ["最近年报"], "multi_year": false, "period": "最近年报", "gm_series": [49.9], "rev_series": [0.9], "np_series": [-0.7], "roe_series": [-16.7], "rev_ttm": 0.9, "np_ttm": 0.8, "ocf_ttm": -0.8, "fcf_ttm": null, "fcf_yield": null, "ocf_yield": -29.8, "gm_median": 49.9, "gm_std": null, "gm_stab": null, "gm_chg_2022": null, "npm_median": -87.8, "roe_median": -16.7, "commodity": false, "hard_ratio": 7.8, "fix_assets": 0.5, "hard_note": "PP&E 毛额 × 0.5 近似净额", "goodwill_ratio": null, "pb_calc": null, "capex_dep": null, "interest_debt": null, "debt_ebitda": null, "ebitda": -0.9, "debt_ratio": 25.3, "debt_mv": null, "payout": 0.0, "div_years": 0, "rev_cagr3": null, "np_cagr3": null, "rev_yoy": -6.2, "np_yoy": 46.1, "np_vol": null, "loss_years": 0, "far_share": 0.0, "earn_yield": 32.1, "consensus_n": 0, "fwd_pe": null, "fwd_pe2": null, "fwd_g1": null, "fwd_g2": null, "peg": null, "consensus_disp": null, "mainbz": [], "ret_prev_year": null, "ret_prev2_year": null, "ret_pivot": null, "prev_year": "", "prev2_year": "", "ret_ytd": -46.4, "ret_20": -14.3, "ret_60": -22.2, "ret_120": -28.2, "ret_250": -49.6, "mdd_250": null, "vol_250": null, "pos_52w": 39.9, "eps": -0.2}, "S": {"duration": 7, "pricing": 57, "hard": 12, "bondness": 13}, "label": "中性", "tags": [], "text": {"像什么": ["PE 3.1 倍、股息率 0.0%、毛利率最新年报 49.9%、固定资产占比 8%、资产负债率 25%:四轴都不突出。"], "为什么(不)算钱的替代品": "只占定价权一条(毛利率 49.9%),硬资产占比 8%。分子能跟上通胀,但没有重置成本对冲;按'定价权·品牌'看,不按硬资产看。", "加息期怎么走": "按行业与估值常规看,没有明确的利率方向性。", "四问": [["当前 FCF 能覆盖多少市值?", "经营现金流/市值 -29.8%(futu 无资本开支,FCF 按经营现金流 × 0.7 近似)。极低或为负。"], ["能否每年提价而不掉量?", "毛利率最新年报 49.9%。能。"], ["资产重置成本随通胀涨吗?", "固定资产占总资产 8%。没有资产可言。"], ["估值里多少来自 5 年后的故事?", "按 PE 3.1 倍 粗算,约 0%(1 − 5/PE)。中等。"]], "价格行为": "近一年 -50%,现价在 52 周高点的 40%;近 20 / 60 / 120 日 -14% / -22% / -28%。", "行业对照": ["同富途行业「医疗设备」144 家中位:PE 26.7 / 股息率 0.0% / 毛利率 57.5% / 固定资产占比 10% / 分红率 0%。", "Standard BioTools:PE 比行业中位低 23.6倍;股息率 与行业中位持平;毛利率 比行业中位低 7.6个百分点;固定资产占比 比行业中位低 1.8个百分点。"]}}